Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Asset disposition
Credit agrmnt [a]
Director departure
Inv. presentation
Quarterly results
Acq. announced

PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/08/2019 4 Pina Kenneth (SVP, GC,Compliance Off & Sec) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Paid exercise price by delivering 417 shares @ $0.449, valued at $187.2
08/10/2018 4 Pina Kenneth (SVP, GC & Compliance Off.) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Paid exercise price by delivering 411 shares @ $1.86, valued at $764.5
08/10/2018 4 Whaley Glenn (VP of Fin, PAO & Controller) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Paid exercise price by delivering 84 shares @ $1.86, valued at $156.2
08/10/2018 4 Sedor John A (Chairman of Board and CEO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Paid exercise price by delivering 685 shares @ $1.86, valued at $1.3k
08/10/2018 4 Smith Angus W. (SVP, CBO & Principal Fin Off) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Paid exercise price by delivering 282 shares @ $1.86, valued at $524.5
07/27/2018 4 Sedor John A (Chairman of Board and CEO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Paid exercise price by delivering 11,982 shares @ $2.53, valued at $30.3k
05/23/2018 4 Swirsky Douglas J (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 25,000 options to buy @ $2.63, valued at $65.8k
05/23/2018 4 Leone John R (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 25,000 options to buy @ $2.63, valued at $65.8k
05/23/2018 4 LANGER DENNIS (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 25,000 options to buy @ $2.63, valued at $65.8k
05/23/2018 4 LEUNG GABRIEL (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 25,000 options to buy @ $2.63, valued at $65.8k
04/09/2018 4 Pina Kenneth (SVP, GC & Compliance Off.) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Paid exercise price by delivering 446 shares @ $2.74, valued at $1.2k
03/16/2018 4 Smith Angus W. (SVP, Chief Bus Off & PFO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 5,000 shares @ $0
Granted 15,000 options to buy @ $2.46, valued at $36.9k
03/16/2018 4 Pina Kenneth (SVP, GC & Compliance Off) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 5,000 shares @ $0
Granted 15,000 options to buy @ $2.46, valued at $36.9k
03/16/2018 4 Whaley Glenn (Interim VP Fin, PAO & Controll) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 2,600 shares @ $0
Granted 7,800 options to buy @ $2.46, valued at $19.2k
03/16/2018 4 Sedor John A (Chairman of the Board & CEO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 18,000 shares @ $0
Granted 64,000 options to buy @ $2.46, valued at $157.4k
11/17/2017 4 LANGER DENNIS (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 50,000 options to buy @ $2.97, valued at $148.5k
11/17/2017 4 LEUNG GABRIEL (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 50,000 options to buy @ $2.97, valued at $148.5k
11/17/2017 4 Leone John R (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 50,000 options to buy @ $2.97, valued at $148.5k
11/17/2017 4 Swirsky Douglas J (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 50,000 options to buy @ $2.97, valued at $148.5k
08/09/2017 4 Golembiewski Michael Joseph (VP Finance, Controller, CAO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 3,300 shares @ $0
Granted 10,000 options to buy @ $2.92, valued at $29.2k
08/09/2017 4 Pina Kenneth (SVP, Gen Counsel & Comp Off) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 6,000 shares @ $0
Granted 18,000 options to buy @ $2.78, valued at $50k
08/09/2017 4 Miao Graham G (President and CFO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 6,667 shares @ $0
Granted 20,000 options to buy @ $2.78, valued at $55.6k
08/09/2017 4 Sedor John A (Chairman of Board and CEO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 10,000 shares @ $0
Granted 30,000 options to buy @ $2.78, valued at $83.4k
07/31/2017 4 Miao Graham G (President and CFO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Paid exercise price by delivering 8,132 shares @ $3.15, valued at $25.6k
07/31/2017 4 Sedor John A (Board Chairman and CEO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Paid exercise price by delivering 13,293 shares @ $3.15, valued at $41.9k
01/17/2017 4 Pina Kenneth (S VP, Gen Counsel and Comp Off) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
11/22/2016 4 LEUNG GABRIEL (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
11/07/2016 4 Miao Graham G (PRESIDENT AND CFO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
11/07/2016 4 Sedor John A (CHAIRMAN OF THE BOARD AND CEO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
05/31/2016 4 Konidaris Tasos (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 40,000 options to buy @ $0.45, valued at $18k
05/31/2016 4 ELMS STEVE (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Bought 40,000 options to buy @ $0.45, valued at $18k
05/11/2016 4 Sedor John A (Interim CEO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 210,000 options to buy @ $0.52, valued at $109.2k
02/29/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
02/29/2016 4 Golembiewski Michael Joseph (VP Finance, Controller, CAO) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 65,000 options to buy @ $2.14, valued at $139.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy